Is MPHYF or JNJ a better dividend investment in 2026?

MPHYF currently yields 200000.00% with a 5% 5-year dividend growth rate. JNJ yields 2.14% with 5.8% growth. The better choice depends on your goal: MPHYF offers higher current income.

What is the dividend yield difference between MPHYF and JNJ?

MPHYF has a forward dividend yield of 200000.00% ($2.00/share annually). JNJ yields 2.14% ($5.20/share annually). The yield gap is 199997.86 percentage points.

Home › Compare › MPHYF vs JNJ

MPHYF vs JNJ: Dividend Comparison 2026

MPHYF yields 200000.00% · JNJ yields 2.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 MPHYF wins by $4.911780474428384e+29M in total portfolio value

INVESTMENT

TIME HORIZON10 years

MPHYF

● Live price

200000.00%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4.911780474428384e+29M

Annual income

$490,695,411,370,591,700,000,000,000,000,000,000.00

Full MPHYF calculator →

JNJ

Johnson & Johnson

● Live price

2.14%

Share price

$242.49

Annual div

$5.20

5Y div CAGR

28%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.5K

Annual income

$4,749.88

Full JNJ calculator →

Portfolio growth — MPHYF vs JNJ

📍 MPHYF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	MPHYF	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, MPHYF + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

MPHYF pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MPHYF

Annual income on $10K today (after 15% tax)

$17,000,000.00/yr

After 10yr DRIP, annual income (after tax)

$417,091,099,665,002,940,000,000,000,000,000,000.00/yr

JNJ

Annual income on $10K today (after 15% tax)

$182.28/yr

After 10yr DRIP, annual income (after tax)

$4,037.40/yr

At 15% tax rate, MPHYF beats the other by $417,091,099,665,002,940,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MPHYF + JNJ for your $10,000?

MPHYF: 50%JNJ: 50%

100% JNJ50/50100% MPHYF

Portfolio after 10yr

$2.455890237214192e+29M

Annual income

$245,347,705,685,295,860,000,000,000,000,000,000.00/yr

Blended yield

99.90%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

MPHYF

Analyst Ratings

Buy

Consensus: Buy

Altman Z

-3.7

Piotroski

3/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

-5.7% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MPHYF buys

JNJ buys

No recent congressional trades found for MPHYF or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricMPHYFJNJ

Forward yield	200000.00% ✓	2.14%
Annual dividend / share	$2.00	$5.20 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	28% ✓
Portfolio after 10y	$4.911780474428384e+29M	$30.5K ✓
Annual income after 10y	$490,695,411,370,591,700,000,000,000,000,000,000.00 ✓	$4,749.88
Total dividends collected	$4.911464459982279e+29M	$15.6K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare
Analyst consensus	Buy	Buy

Year-by-year: MPHYF vs JNJ ($10,000, DRIP)

Year	MPHYF Portfolio	MPHYF Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$20,010,700	$20,000,000.00	$10,594	$274.49	+$20.00M → MPHYF
2	$37,424,589,019	$37,403,177,570.09	$11,294	$360.69	+$37424.58M → MPHYF
3	$65,416,215,188,220	$65,376,170,877,969.18	$12,133	$476.91	+$65416215.18M → MPHYF
4	$106,868,230,495,008,900	$106,798,235,144,757,520.00	$13,156	$635.42	+$106868230495.00M → MPHYF
5	$163,172,871,735,896,870,000	$163,058,522,729,267,200,000.00	$14,432	$854.61	+$163172871735896.88M → MPHYF
6	$232,854,599,801,468,860,000,000	$232,680,004,828,711,460,000,000.00	$16,056	$1,162.76	+$232854599801468864.00M → MPHYF
7	$310,570,858,137,017,100,000,000,000	$310,321,703,715,229,540,000,000,000.00	$18,175	$1,604.53	+$310570858137017057280.00M → MPHYF
8	$387,148,154,301,613,200,000,000,000,000	$386,815,843,483,406,600,000,000,000,000.00	$21,009	$2,252.68	+$3.871481543016132e+23M → MPHYF
9	$451,061,749,763,281,040,000,000,000,000,000	$450,647,501,238,178,360,000,000,000,000,000.00	$24,911	$3,229.73	+$4.510617497632811e+26M → MPHYF
10	$491,178,047,442,838,440,000,000,000,000,000,000	$490,695,411,370,591,700,000,000,000,000,000,000.00	$30,458	$4,749.88	+$4.911780474428384e+29M → MPHYF

MPHYF vs JNJ: Complete Analysis 2026

MPHYF — Stock

McPhy Energy S.A. designs, develops, and supplies hydrogen production, storage, and distribution equipment for hydrogen energy, hydrogen mobility, and industrial hydrogen markets. The company offers alkaline electrolyzers; and hydrogen storage solutions and fuel cells. It also designs hydrogen stations; and provides integrated hydrogen solutions. It operates in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company was incorporated in 2007 and is headquartered in La Motte, France.

Full MPHYF Calculator →

JNJ — Healthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →

📬

Get this MPHYF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MPHYF vs SCHD MPHYF vs JEPI MPHYF vs O MPHYF vs KO MPHYF vs MAIN MPHYF vs ABBV MPHYF vs MRK MPHYF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.